Ugrás a tartalomra
Merck
Összes fotó(1)

Fontos dokumentumok

AP112P

Sigma-Aldrich

Goat Anti-Human IgG Antibody, HRP conjugate

Chemicon®, from goat

Szinonimák:

Anti-Human IgG HRP Conjugate

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez


About This Item

UNSPSC kód:
12352203
eCl@ss:
32160702
NACRES:
NA.46

biológiai forrás

goat

Minőségi szint

konjugátum

peroxidase conjugate

antitest forma

affinity isolated antibody

antitest terméktípus

secondary antibodies

klón

polyclonal

Forma

lyophilized

faj reaktivitás

human

gyártó/kereskedő neve

Chemicon®

technika/technikák

ELISA: suitable
western blot: suitable

izotípus

IgG

kiszállítva

wet ice

tárolási hőmérséklet

2-8°C

célzott transzláció utáni módosítás

unmodified

Általános leírás

Immunoglobulin G (IgG) belongs to the immunoglobulin family and is a widely expressed serum antibody. It is a glycoprotein and mainly helps in immune defense. About 70 percent of the total immunoglobulin consists of IgG. IgG is a monomeric immunoglobulin, made up of four polypeptide chains. It consists of two 50 kDa heavy chains (gamma) and two 25kDa light chains. These chains are inter-linked by di-sulfide bonds. Each molecule has two antigen binding sites. IgG is the most abundant immunoglobulin. It is approximately equally distributed in blood and in tissue liquids, constituting 75% of serum immunoglobulins in humans. There are 4 subclasses: IgG1 (66%), IgG2 (23%), IgG3 (7%) and IgG4 (4%).

Egyediség

The antibody reacts with the heavy chains of human IgG and with the light chains common to most human immunoglobulins.

Immunogén

Prepared from purified human IgG.

Alkalmazás

Goat Anti-Human IgG Antibody, HRP conjugate has been used:
  • to detect the bound immunoglobulin G (IgG) in enzyme-linked immunosorbent assay (ELISA) assay
  • in immunohistochemistry or cytochemistry at a dilution of 1:500 - 1:5,000
  • for western blotting with chromogenic substrates at a dilution of 1:5,000 - 1:100,000 and with ECL substrates at a dilution of 1:10,000 - 1:200,000.
  • for EIA at a dilution of 1:5,000-1:100,000

Biokémiai/fiziológiai hatások

Immunoglobulin G (IgG) participates in hypersensitivity type II and type III. It initiates the classical pathway of the complement system and also neutralizes virus particles and toxins. Maternal IgG can pass through the human placenta to fetus providing immune defense for the neonate against infections. It facilitates antibody-dependent cell-mediated cytotoxicity (ADCC). IgG is digested by papain to produce fragment antigen-binding (Fab). Pepsin digestion of IgG results in the formation of fragment crystallizable (Fc). IgG levels in severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infected patients may be useful to evaluate the severity and prognosis of coronavirus disease 2019 (COVID-19).

Fizikai forma

Purified by immunoaffinity chromatography using antigen coupled to agarose beads. Lyophilized. Buffer is 0.01 M Sodium Phosphate, 0.25 M NaCl, pH 7.6 with 15 mg/mL BSA. Contains no preservative.

Tárolás és stabilitás

Maintain lyophilized product at 2°-8°C for up to 12 months from date of receipt. After reconstitution the product is stable for six weeks at 2°-8°C as an undiluted liquid. Reconstitute vial with 2 mL of distilled water. For extended storage after reconstitution, add an equal volume of glycerol to make a final concentration of 50% glycerol followed by storage at -20°C in undiluted aliquots for up to 12 months. Please note the concentration of antibody (and buffer salts) will decrease to one-half of the original after the addition of glycerol and final working dilutions must be adjusted accordingly. Avoid repeated freeze thaw cycles.

WARNING:
Use of sodium azide as a preservative will substantially inhibit the enzyme activity of HRP.

Egyéb megjegyzések

Research Category: Secondary & Control Antibodies
Research Sub Category
Whole Immunoglobulin Secondary Antibodies

Jogi információk

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Jogi nyilatkozat

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Nem találja a megfelelő terméket?  

Próbálja ki a Termékválasztó eszköz. eszközt

Tárolási osztály kódja

13 - Non Combustible Solids

WGK

WGK 3

Lobbanási pont (F)

Not applicable

Lobbanási pont (C)

Not applicable


Analitikai tanúsítványok (COA)

Analitikai tanúsítványok (COA) keresése a termék sarzs-/tételszámának megadásával. A sarzs- és tételszámok a termék címkéjén találhatók, a „Lot” vagy „Batch” szavak után.

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Fulminant Amoebic Colitis: Role of the Innate and Adaptive Immune Responses
Colitis (2012)
Sun Woo Lim et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 33(10), 10889-10901 (2019-07-04)
Synthetic biologic drugs are highly successful for induction therapy in transplantation, but the development of novel biologics is limited because of the high cost of synthesis and purification. In this study, we developed a novel strategy for the production of
Kyle E Korolowicz et al.
Cells, 10(9) (2021-09-29)
Current treatment options for patients infected with hepatitis B virus (HBV) are suboptimal, because the approved drugs rarely induce cure due to the persistence of the viral DNA genome in the nucleus of infected hepatocytes, and are associated with either
Sun Woo Lim et al.
The Korean journal of internal medicine, 37(5), 1031-1049 (2022-06-21)
We previously proposed minicircle vector technology as the potential platform for the development and production of new biologics. In this study, we have designed a novel target molecule for the treatment of allograft rejection and evaluated its feasibility as the
The impact of timing of maternal influenza immunization on infant antibody levels at birth
Zhong Z, et al.
Clinical and Experimental Immunology, 195(2), 139-152 (2019)

Related Content

Products and support for mpox research, offering world-class reagents for immunoassay and molecular assay development.

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással